Eli Lilly (LLY) Q4 2024 Earnings Call Transcript
Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q4 2024 earnings call. [Operator ...
Novo Nordisk's Innovation Supports a Wide Moat and GLP-1 Market Growth
We expect Novo to gain $75 billion of a more than $200 billion global GLP-1 market in diabetes and obesity by 2031, ahead of semaglutide's 2032 patent expiration, with Lilly standing as the firm's key ...
manilatimes1d
Revive Health Plan Rebrands as Rixa Health: Pioneering a New Era in Telehealth Innovation
Perrysburg, Ohio, Feb. 05, 2025 (GLOBE NEWSWIRE) -- ...